The syringe driver continuous subcutaneous infusions in palliative care. Guidelines for syringe driver management in palliative care. Water for injection is recommended to dilute drugs unless otherwise stated. Continuous subcutaneous infusion when added to a syringe driver the recommended diluent is water for injection. Stelara support injection resources janssen carepath. An initial subcutaneous injection may also be required as a loading dose to manage the patients symptoms for the initial two to four hours of syringe driver use until the medicines in the infusion reach effective blood plasma levels. It has a needle that is slightly longer than an insulin syringe. When an infusion is due to be changed, a delay of an hour or two should not cause problems if the patients. Ondansetron 2 mgml solution for injection summary of. Jul 24, 2018 since then, many more products have been approved by the ema or the fda for subcutaneous selfadministration, typically using an infusion pump or syringe driver pump. One part of the yarm can be connected to a syringe driver or.
Management of subcutaneous infusions in palliative care. Procedure for the use of mckinley t34 syringe driver to. This device can be attached to a syringe driver for continuous infusions of prescribed medications either on an alaris asena gh mk iii inpatient use or a nikit 34 for either inpatient or outpatient use. This catheter system requires a needle and syringe to administer the medication through the device. T34 syringe driver instruction video for oxfordshire. Instructions for subcutaneous injections medview systems. It 2is long acting and can be given once daily as a bolus injection. In our case series, both water for injection and 0. A prospective, withinpatient, crossover study of continuous intravenous and subcutaneous morphine for chronic pain. To our knowledge, this study is one of the first comprehensive and systematic evaluations of the clinical practice of noncontinuous subcutaneous bolus applications of drugs in an inpatient palliative care unit with a study phase of more than one year. The infusion sets should be changed with every treatment. Given the lack of compatibility data, in all cases, sodium valproate was administered in a separate syringe driver. Battery operated and portable refilled every 24 hours holds 1050ml syringesup to 30ml with lockbox pump identifies type of syringe and size.
The use of subcutaneous levetiracetam in palliative medicine indications for use the treatment of epileptic seizures and status epilepticus in palliative care patients who are unable to take their medications orally and when iv access is not possible or not desired. Subcutaneous administration use of offlabel subcutaneous levetiracetam offers the possibility of maintaining seizure control when the oral route is lost and there is no iv access, without increasing the level of sedation. Avoid giving more than 2ml 8mg as single stat subcutaneous dose. A syringe driver is useful when the oral route of administration is not possible and repeated subcutaneous doses are. Hizentra, vivaglobin, and hyqvia are only available for subcutaneous delivery, but other pi products can be purchased for intravenous or intramuscular use. Jul 21, 2018 setting up my subcutaneous saline infusion for my pots treatment. Subcutaneous infusion devices syringe drivers are commonly used to give comfort in palliative care to treat distressing symptoms when other routes are inappropriate or ineffective. Mckinley t34 syringe driver studied widely and found to be the most safe and reliable of all syringe pumps. This video will describe how to use the saftintima 24 gauge subcutaneous needle by bd canada. A syringe driver helps reduce symptoms by delivering a steady flow of injected medication continuously under the skin. Syringe driver drug compatibilities guide to palliative care practice 2016 sodium chloride 0.
Innovation in medicine has led to the development of novel small molecule and biologic formulations that require parenteral administration via intravenous iv, subcutaneous sc, intramuscular im, or other administration routes via injection. Runs mls per hour but can be set and locked to run over 24 hours only. Subcutaneous administration of drugs in palliative care. The management of subcutaneous sc furosemide by syringe driver. Continuous subcutaneous infusion with desferal and neria infusion sets the patient uses an elastomeric pump or a batterydriven, syringe driver infusion pump to deliver a specified continuous amount of desferal subcutaneously over a selfadministered period. The following are sites where you can give a subcutaneous injection. For safe use of syringe drivers, it is imperative that patients and their carers are provided with education regarding subcutaneous mediation administration via a. For subcutaneous bolus administration haloperidol does not need to be diluted when haloperidol is added to a syringe driver the recommended diluent is water for injection 6. Diazepam, chlorpromazine and prochlorperazine are too.
The syringe driver and the subcutaneous route in palliative. These guidelines recommend a conversion ratio of 1. The effect of dexamethasone on the longevity of syringe. A syringe driver takes 34 hours to establish a steady state drug level in plasma. Rectal administration can be a challenge for carers, both physically and emotionally. Evidencebased information on subcutaneous syringe driver from hundreds of trustworthy sources for health and social care. April 2017 introduction palliative care patients often exhibit multiple symptoms that require the use of numerous drugs. Single drugs used in a subcutaneous infusion over 24 hours in palliative care tables 1a to 1f diluent. Subcutaneous prn dosedoses for anticipatory symptoms subcutaneous starting dose range over 24 hours in syringe driver subcutaneous maximum dose over 24 hours 1. T34 adult syringe driver guidelines nhs harrogate and rural. When the oral route is no longer appropriate, a syringe driver can be used to ensure continued symptom control. One part of the yarm can be connected to a syringe driver or infusion pump. If you can grasp only 1 inch of skin, give the injection at a 45 degree angle.
Subcutaneous syringe pump protocol palliative care see intranet for latest version of this document page 6 of 96 1. Clinical protocol for the use of syringe drivers in palliative care patients. Rehydration palliative care pediatric care post operative pain management scapula. The syringe driver continuous subcutaneous infusions in palliative care 3rd ed. When and how to use a syringe driver in palliative. Syringe driver information for further information on the use of syringe drivers see guidelines for subcutaneous infusion device. Dec 02, 2016 a syringe driver takes 34 hours to establish a steady state drug level in plasma. How to give a subcutaneous injection discharge care. Continuous subcutaneous administration of medicines via the t34 syringe driver for adult palliative care patients.
Using syringe drivers in palliative care within a rural, community setting. Although the device itself has not been adopted universally, it has stimulated interest in the use of csci in palliative care and played a significant role in the modern history of this approach. Subcutaneous sc drug infusion by portable syringe driver has had a significant impact on pain management. Subcutaneous injection is an injection into the fat layer between the skin and the underlying muscle. The use of subcutaneous levetiracetam in palliative medicine. Subcutaneous drug infusion compatibility guidelines. Hypodermoclysis offers the benefit of many subcutaneous sites rather than limited intravenous sites, which means increased patient comfort. If the patient is very frail, or there is a concern about renal failure, use diamorphine 2. Generally the more dilute the contents are, the lower the risk of compatibility problems and injection site reactions. October 2020 introduction palliative care patients often exhibit multiple symptoms that require the use of numerous drugs. A subcutaneous injection is a method of administering medication. A syringe driver is useful when the oral route of administration is not possible and repeated subcutaneous doses are inappropriate, ineffective or impractical. Guidelines for subcutaneous infusion device management in.
If severe renal impairment, seek specialist advice morphine 2. Integrated safety iv catheter system 6 reasons why bd saftintima is the first choice for all your subcutaneous infusion therapy needs. Monitoring the continuous subcutaneous infusion via syringe driver every 4 hours as a minimum. The patient must give their written consent for this to take place. Since then, many more products have been approved by the ema or the fda for subcutaneous selfadministration, typically using an infusion pump or syringe driver pump. If the patient is in pain, vomiting or very agitated, give a stat sc injection of appropriate medication while setting up the syringe driver. Administration of subcutaneous medications in palliative care. This is an extract from the smpc to help you with the administration octreotide. Medicine requirements must be anticipated for a 24 hour period and can result in a loss of flexibility in dosing medicines given by other routes including as needed subcutaneous injections may be required to manage the patients symptoms for the initial four hours of the syringe driver infusion while the medicines reach a plasma. Only use drugs that are known to be effective via the sc route.
Parecoxib is licensed for the shortterm treatment of postoperative pain by intravenous or intramuscular injection 3 and has been given by daily subcutaneous injection for cancer pain. A single stat subcutaneous injection should be given at thesa meti as setting up csci and breakthrough antiemetics should always be prescribed. Continuous subcutaneous administration of medicines using a syringe driver often becomes necessary for the control of symptoms during palliative care. Syringe driver drug compatibilities guide to palliative. Preparations keppra 100 mgml concentrate for solution for infusion. Use of parecoxib by continuous subcutaneous infusion for. You might have been given a syringe driver, to help control pain, sickness, agitation or fits. The use of a subcutaneous or intravenous infusion using a syringe driver to deliver medications has certain advantages. May 19, 2003 for comfort, convenience and therapeutic advantage, many palliative care patients have their medications administered with syringe drivers. Various subcutaneous regimens are suggested in table 27. A subcutaneous injection, as illustrated in the figure to the right, is given into the fatty layer of tissue just under the skin. Its sometimes called a continuous subcutaneous infusion. Find patient medical information for prolia subcutaneous on webmd including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Advantages of subcutaneous drug delivery enable injections. Given the lack of compatibility data, in all cases, sodium valproate was administered in a. Feb 04, 2014 a brief video demonstrating how to insert the saftintima subcutaneous infusion set. Other sources may recommend different oral to parenteral conversion. Syringe driver drug compatibilities guide to palliative care.
Syringe drivers are often required to provide medicines for symptom. Procedure for the use of mckinley t34 syringe driver to deliver a continuous subcutaneous infusion in palliative care for adults page 8 of 41 9. The subcutaneous administration of medications using a syringe driver is a common and accepted practice in palliative care for assisting with the management. Subcutaneous injection sites, how to give subcutaneous. Subcutaneous injections are given with a very small needle that causes little or no discomfort.
In this type of injection, a short needle is used to inject a drug into the tissue layer. The syringe driver is used to administer a continuous subcutaneous. Continuous subcutaneous administration of medicines using a syringe driver often. The subcutaneous sc administration of levetiracetam is unlicensed, but published reports and case studies suggest administration by either sc or continuous subcutaneous infusion csci at concentrations of up to 100mgml is well tolerated. The gp and district nurse must be confident that all safety, risk assessments, consent and ethical considerations have been addressed before agreeing to train and. Feb 03, 2020 subcutaneous injections can be given straight in at a 90 degree angle or at a 45 degree angle. When and how to use a syringe driver in palliative care. Whilst the preferred route of medication administration in paediatric palliative care is the oral one, there may be occasions when this is impractical or undesirable. Painbreathlessness nb if already on oral opioids, see below for conversion. A brief video demonstrating how to insert the saftintima subcutaneous infusion set. Octreotide 50 100 500 micrograms ml, solution for injection in prefilled syringe the following information is intended for medical or healthcare professionals only. Sodium valproate as a continuous subcutaneous infusion. First used in naples in 1865 subcutaneous infusion is increasingly and widely used for the following therapies.
Continuous subcutaneous administration of medicines via the. Given over 24 hours via a syringe pump csci using water for injection as diluent. Janssen nurse support can help answer their questions about giving themselves an injection at home, preparing their injection site prior to selfinjecting, and properly disposing of their used syringe. Drugs for subcutaneous administration in syringe drivers. Give the injection at a 90 degree angle if you can grasp 2 inches of skin between your thumb and first finger. If the combination is not listed in this guideline or its companion document consult. Subcutaneous injections can be given straight in at a 90 degree angle or at a 45 degree angle.
353 597 1288 1004 488 588 204 947 390 1201 1409 1694 380 1537 585 977 1108 1559 1411 911 40 1081 1342 519 259 1272 1162 741 1365 783 574 251 885